Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation

Noriyoshi Kajihara, Shigeki Morita, Takahiro Nishida, Hideki Tatewaki, Masataka Eto, Kensuke Egashira, Hisataka Yasui

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background - Monocyte chemoattractant protein-1 (MCP-1), a potent chemotactic factor for monocytes, is induced during ischemia-reperfusion. As monocytes might play an important causative role in reperfusion injury, we investigated if inhibition of monocyte activation could attenuate ischemia-reperfusion injury and thereby improve cardiac preservation. To inhibit monocyte activation, we transfected a dominant-negative inhibitor of MCP-1 (7ND) gene in an animal model. Methods and Results - We used an isolated rabbit heart preparation perfused with support-rabbit blood and transfected 7ND genes to skeletal muscle of the support rabbits (n=7) using electroporation technique; causing an elevation of serum 7ND level to 20±7 pg/mL at 5 days after transfection. Animals receiving empty plasmid served as controls (n=7). Five days after transfection, hearts from other rabbits were excised, stored in UW solution for 6hours, and perfused with blood from transfected support rabbits. The 7ND group showed better cardiac output (128.7±17.9 versus 81.6±19.8 mL/min; P<0.01), lower serum CK-MB levels (5.0±1.8 versus 11.1±2.9 ng/mL; P<0.01), lower serum IL-1β levels (257.2±23.2 versus 311.2±37.4pg/mL; P<0.05), and lower serum TNF-α levels (19.0±8.4 versus 35.1± 13.0pg/mL; P<0.05). The numbers of infiltrating cells in myocardium were significantly reduced in the 7ND group. Conclusions - Inhibition of MCP-1 with 7ND gene transfection reduced cytokine activation, attenuated myocardial damage, and improved cardiac function after 6 hours of preservation. These results show that MCP-1 plays an important role in ischemia-reperfusion injury.

Original languageEnglish
Pages (from-to)II213-II218
JournalCirculation
Volume108
Issue number10 SUPPL.
Publication statusPublished - Sep 9 2003
Externally publishedYes

Fingerprint

Chemokine CCL2
Transfection
Monocytes
Rabbits
Reperfusion Injury
Genes
Serum
Electroporation
Chemotactic Factors
Interleukin-1
Cardiac Output
Reperfusion
Myocardium
Skeletal Muscle
Plasmids
Ischemia
Animal Models
Cell Count
Cytokines

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation. / Kajihara, Noriyoshi; Morita, Shigeki; Nishida, Takahiro; Tatewaki, Hideki; Eto, Masataka; Egashira, Kensuke; Yasui, Hisataka.

In: Circulation, Vol. 108, No. 10 SUPPL., 09.09.2003, p. II213-II218.

Research output: Contribution to journalArticle

Kajihara, Noriyoshi ; Morita, Shigeki ; Nishida, Takahiro ; Tatewaki, Hideki ; Eto, Masataka ; Egashira, Kensuke ; Yasui, Hisataka. / Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation. In: Circulation. 2003 ; Vol. 108, No. 10 SUPPL. pp. II213-II218.
@article{e1cfd537f16741e5901e7cbf1a0aaecf,
title = "Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation",
abstract = "Background - Monocyte chemoattractant protein-1 (MCP-1), a potent chemotactic factor for monocytes, is induced during ischemia-reperfusion. As monocytes might play an important causative role in reperfusion injury, we investigated if inhibition of monocyte activation could attenuate ischemia-reperfusion injury and thereby improve cardiac preservation. To inhibit monocyte activation, we transfected a dominant-negative inhibitor of MCP-1 (7ND) gene in an animal model. Methods and Results - We used an isolated rabbit heart preparation perfused with support-rabbit blood and transfected 7ND genes to skeletal muscle of the support rabbits (n=7) using electroporation technique; causing an elevation of serum 7ND level to 20±7 pg/mL at 5 days after transfection. Animals receiving empty plasmid served as controls (n=7). Five days after transfection, hearts from other rabbits were excised, stored in UW solution for 6hours, and perfused with blood from transfected support rabbits. The 7ND group showed better cardiac output (128.7±17.9 versus 81.6±19.8 mL/min; P<0.01), lower serum CK-MB levels (5.0±1.8 versus 11.1±2.9 ng/mL; P<0.01), lower serum IL-1β levels (257.2±23.2 versus 311.2±37.4pg/mL; P<0.05), and lower serum TNF-α levels (19.0±8.4 versus 35.1± 13.0pg/mL; P<0.05). The numbers of infiltrating cells in myocardium were significantly reduced in the 7ND group. Conclusions - Inhibition of MCP-1 with 7ND gene transfection reduced cytokine activation, attenuated myocardial damage, and improved cardiac function after 6 hours of preservation. These results show that MCP-1 plays an important role in ischemia-reperfusion injury.",
author = "Noriyoshi Kajihara and Shigeki Morita and Takahiro Nishida and Hideki Tatewaki and Masataka Eto and Kensuke Egashira and Hisataka Yasui",
year = "2003",
month = "9",
day = "9",
language = "English",
volume = "108",
pages = "II213--II218",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "10 SUPPL.",

}

TY - JOUR

T1 - Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation

AU - Kajihara, Noriyoshi

AU - Morita, Shigeki

AU - Nishida, Takahiro

AU - Tatewaki, Hideki

AU - Eto, Masataka

AU - Egashira, Kensuke

AU - Yasui, Hisataka

PY - 2003/9/9

Y1 - 2003/9/9

N2 - Background - Monocyte chemoattractant protein-1 (MCP-1), a potent chemotactic factor for monocytes, is induced during ischemia-reperfusion. As monocytes might play an important causative role in reperfusion injury, we investigated if inhibition of monocyte activation could attenuate ischemia-reperfusion injury and thereby improve cardiac preservation. To inhibit monocyte activation, we transfected a dominant-negative inhibitor of MCP-1 (7ND) gene in an animal model. Methods and Results - We used an isolated rabbit heart preparation perfused with support-rabbit blood and transfected 7ND genes to skeletal muscle of the support rabbits (n=7) using electroporation technique; causing an elevation of serum 7ND level to 20±7 pg/mL at 5 days after transfection. Animals receiving empty plasmid served as controls (n=7). Five days after transfection, hearts from other rabbits were excised, stored in UW solution for 6hours, and perfused with blood from transfected support rabbits. The 7ND group showed better cardiac output (128.7±17.9 versus 81.6±19.8 mL/min; P<0.01), lower serum CK-MB levels (5.0±1.8 versus 11.1±2.9 ng/mL; P<0.01), lower serum IL-1β levels (257.2±23.2 versus 311.2±37.4pg/mL; P<0.05), and lower serum TNF-α levels (19.0±8.4 versus 35.1± 13.0pg/mL; P<0.05). The numbers of infiltrating cells in myocardium were significantly reduced in the 7ND group. Conclusions - Inhibition of MCP-1 with 7ND gene transfection reduced cytokine activation, attenuated myocardial damage, and improved cardiac function after 6 hours of preservation. These results show that MCP-1 plays an important role in ischemia-reperfusion injury.

AB - Background - Monocyte chemoattractant protein-1 (MCP-1), a potent chemotactic factor for monocytes, is induced during ischemia-reperfusion. As monocytes might play an important causative role in reperfusion injury, we investigated if inhibition of monocyte activation could attenuate ischemia-reperfusion injury and thereby improve cardiac preservation. To inhibit monocyte activation, we transfected a dominant-negative inhibitor of MCP-1 (7ND) gene in an animal model. Methods and Results - We used an isolated rabbit heart preparation perfused with support-rabbit blood and transfected 7ND genes to skeletal muscle of the support rabbits (n=7) using electroporation technique; causing an elevation of serum 7ND level to 20±7 pg/mL at 5 days after transfection. Animals receiving empty plasmid served as controls (n=7). Five days after transfection, hearts from other rabbits were excised, stored in UW solution for 6hours, and perfused with blood from transfected support rabbits. The 7ND group showed better cardiac output (128.7±17.9 versus 81.6±19.8 mL/min; P<0.01), lower serum CK-MB levels (5.0±1.8 versus 11.1±2.9 ng/mL; P<0.01), lower serum IL-1β levels (257.2±23.2 versus 311.2±37.4pg/mL; P<0.05), and lower serum TNF-α levels (19.0±8.4 versus 35.1± 13.0pg/mL; P<0.05). The numbers of infiltrating cells in myocardium were significantly reduced in the 7ND group. Conclusions - Inhibition of MCP-1 with 7ND gene transfection reduced cytokine activation, attenuated myocardial damage, and improved cardiac function after 6 hours of preservation. These results show that MCP-1 plays an important role in ischemia-reperfusion injury.

UR - http://www.scopus.com/inward/record.url?scp=0042416948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042416948&partnerID=8YFLogxK

M3 - Article

C2 - 12970235

AN - SCOPUS:0042416948

VL - 108

SP - II213-II218

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 10 SUPPL.

ER -